Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GC Holdings
Yongin, Gyeonggi-do, South Korea
- Ownership
- Private
- Employees
- ~1766
- Development stage
- Other
01
Overview
GC (formerly Green Cross Holdings) is a South Korean biopharmaceutical leader in vaccines, plasma derivatives, biologics, and orphan drugs. It has commercialized global firsts in vaccines and hemophilia agents, with an active focus on cell therapy and mRNA therapeutics. Its marketed products include hepatitis B vaccine (Hepavax B), pandemic hemorrhagic fever vaccine (Hantavax), and enzyme replacement for Hunter syndrome (Hunterase). Key clinical and commercial assets span blood products, recombinant therapeutic proteins, and innovative drug modalities for rare and infectious diseases.
- Therapeutic areas
- ImmunologyMetabolic DisordersInfectious DiseasesRare DiseasesGastroenterologyHematologyPulmonologyCardiovascularOncologyNeurology
- Modalities
- Small moleculeMonoclonal antibodyBiologicRecombinant proteinVaccineCell therapy
- Industry
- Biotech
02
Partnerships
Chong Kun Dang PharmaceuticalDong-A ST Co.Kanaph Therapeutics
Beyond the preview
Go deeper on GC Holdings.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GC Holdings.